Skip to main content
OpenTrials
Completed

NCT Number: NCT04201899

HYPOPhosphatemia in the Intensive Care: A One-day Point Prevalence Survey

The point prevalence survey aims at defining the until now unknown real prevalence of hypophosphatemia (defined as blood phosphate value < 0.8 mmol/l) in international critical care settings

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Critically Ill Critical Illness Disease Attributes Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Observational

Primary location

Tartu University Hospital, Tartu, Estonia

Loading trial locations.

About this study

The survey will be conducted on one single day in each centre (D-day), within a week defined by the project coordinator (International PI). On D-Day, the local investigators will be asked

  • to complete questions aiming at describing their ICU (number of beds, number of patients present on D-Day, type medical/surgical/other, local phosphate reference value, presence of an hypophosphatemia treatment protocol in the ICU and route of phosphate delivery in case of hypophosphatemia)
  • to indicate how many patients had a blood phosphate <0.08 mmol/l, for each patient with hypophosphatemia, to record the exact lowest value on D-Day, and to record age, number of days in ICU on D-Day, presence (or not) of artificial nutrition and continuous renal replacement therapy, if any phosphate administration is ongoing Data will be recorded in and electronic Case Report Form (e-CRF) in REDCap, and analysed with descriptive statistics No outcome data will be recorded (pure point-prevalence) There is no intervention

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

blood phosphate value < 0.8 mmol -

Exclusion criteria

Blood phosphate value >0.8 mmol/l

-

Treatment and study plan

No intervention - pure observation

Dietary Supplement

Phosphate administration (yes or no)

Primary outcomes

  1. Prevalence of hypophosphatemia

    Time frame: 1 day

    Blood value < 0.8 mmol/l

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Vaudois

Other

Collaborators

  • European Society of Intensive Care Medicine

Registry information

Official study title

Hypophosphatemia in the ICU - A One-day Point Prevalence Survey

Acronym: HYPO-P-ICU

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Dec 17, 2019
Registry last updated
Feb 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.